Pneumococcal Polysaccharide Vaccination in Pediatric Inflammatory Bowel Disease

Pneumococcal Polysaccharide Vaccination in Pediatric Inflammatory Bowel Disease

According to current recommendations, in addition to 13-valent pneumococcal conjugate vaccine (PCV13) series, all children with inflammatory bowel disease (IBD) aged ≥2 years, with planned or current immunosuppression, should receive pneumococcal polysaccharide vaccine (PPSV23). The primary aim was...

Full description

Bibliographic Details
Main Authors:	Tsega Temtem MD, John Whitworth MD, Bindiya Bagga MD
Format:	Article
Language:	English
Published:	SAGE Publishing 2019-05-01
Series:	Global Pediatric Health
Online Access:	https://doi.org/10.1177/2333794X19849754

Similar Items

Weekly Folic Acid Is a Convenient and Well-Tolerated Alternative to Daily Dosing in Pediatric Patients with Inflammatory Bowel Disease on Methotrexate
by: Tsega Adera Temtem, et al.
Published: (2023-03-01)

Pneumococcal Conjugate Vaccination Followed by Pneumococcal Polysaccharide Vaccination in Lung Transplant Candidates and Recipients
by: Thijs W. Hoffman, MD, et al.
Published: (2020-06-01)

Effectiveness of Pneumococcal Polysaccharide Vaccine for Preschool-Age Children with Chronic Disease
by: Anthony E. Fiore, et al.
Published: (1999-12-01)

23-Valent Pneumococcal Polysaccharide Vaccine Uptake in the United States Air Force HIV Program
by: Thad F. Ocampo MD, et al.
Published: (2016-07-01)

Pneumococcal vaccination in persons living with HIV: Pneumococcal conjugate, polysaccharide or both?
by: Bhavna Dhingra, et al.
Published: (2020-12-01)

The effect of age on the response to the pneumococcal polysaccharide vaccine
by: Nahm Moon H, et al.
Published: (2010-03-01)

Immunogenicity, safety and efficacy of 23-valent pneumococcal polysaccharide vaccine in patients with inflammatory joint diseases (preliminary data)
by: M. M. Baranova, et al.
Published: (2021-08-01)

Triptych of the Hermit Saints: pneumococcal polysaccharide vaccines for the elderly
by: Rijkers GT, et al.
Published: (2018-03-01)

Polysaccharide responsiveness is not biased by prior pneumococcal-conjugate vaccination.
by: Jens Magnus Bernth-Jensen, et al.
Published: (2013-01-01)

Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
by: Salsench Elisabet, et al.
Published: (2010-03-01)

Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine against Invasive Pneumococcal Disease in Adults, Japan, 2013–2017
by: Reiko Shimbashi, et al.
Published: (2020-10-01)

Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccination.
by: Anita H J van den Biggelaar, et al.
Published: (2017-01-01)

Adalimumab in Pediatric Inflammatory Bowel Disease
by: So Yoon Choi, et al.
Published: (2022-04-01)

Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials
by: Lipsky Benjamin A, et al.
Published: (2000-09-01)

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
by: James T. Peterson, et al.
Published: (2019-03-01)

No long-term evidence of hyporesponsiveness after use of pneumococcal conjugate vaccine in children previously immunized with pneumococcal polysaccharide vaccine
by: Licciardi, P, et al.
Published: (2016)

ASSESSMENT OF THE IMMUNOGENICITY AND SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH RHEUMATIC DISEASES
by: M. S. Naumtseva, et al.
Published: (2016-02-01)

Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis.
by: Gerhard Falkenhorst, et al.
Published: (2017-01-01)

Cost-effectiveness of the 13-valent pneumococcal conjugate vaccine in adults in Portugal versus “no vaccination” and versus vaccination with the 23-valent pneumococcal polysaccharide vaccine
by: Miguel Gouveia, et al.
Published: (2019-04-01)

Severe Inflammatory Response in Myelodysplastic Syndrome and Trisomy 8 Following 23-Valent Polysaccharide Pneumococcal Vaccine Administration
by: Hirohisa Fujikawa, et al.
Published: (2021-02-01)

Pediatric Invasive Pneumococcal Disease (IPD) in Yogyakarta, Indonesia: A Case Series
by: Eggi Arguni MD, PhD, et al.
Published: (2022-06-01)

Vaccine effectiveness of the pneumococcal polysaccharide and conjugated vaccines in elderly and high-risk populations in preventing invasive pneumococcal disease: a systematic search and meta-analysis
by: Melina Gade Sikjær, et al.
Published: (2023-01-01)

Influence of Natural Polysaccharides on Intestinal Microbiota in Inflammatory Bowel Diseases: An Overview
by: Qi Li, et al.
Published: (2022-04-01)

Natural Food Polysaccharides Ameliorate Inflammatory Bowel Disease and Its Mechanisms
by: Yikun Wang, et al.
Published: (2021-06-01)

EXPERIENCE OF PROPHYLAXIS OF ACUTE RESPIRATORY INFECTIONS IN CHILDREN WITH PNEUMOCOCCAL POLYSACCHARIDE VACCINE
by: A.A. Ruleva, et al.
Published: (2010-01-01)

EXPERIENCE OF PROPHYLAXIS OF ACUTE RESPIRATORY INFECTIONS IN CHILDREN WITH PNEUMOCOCCAL POLYSACCHARIDE VACCINE
by: A.A. Ruleva, et al.
Published: (2010-11-01)

Immunogenicity of a 23-valent pneumococcal polysaccharide vaccine in Brazilian elderly
by: V. Simonsen, et al.
Published: (2005-02-01)

Antibody response to pneumococcal capsular polysaccharide vaccine in Down syndrome patients
by: B.T. Costa-Carvalho, et al.
Published: (2006-12-01)

The Use of 23-Valent Pneumococcal Polysaccharide Vaccine in Patients with Rheumatoid Arthritis
by: M. S. Naumtseva, et al.
Published: (2015-08-01)

OXIDATIVE STRESS AND INFLAMMATORY BOWEL DISEASE IN PEDIATRICS
by: M. Panayotova
Published: (2023-12-01)

Diet and Nutrition in Pediatric Inflammatory Bowel Diseases
by: Ugo Cucinotta, et al.
Published: (2021-02-01)

Dermatological Manifestations in Pediatric Inflammatory Bowel Disease
by: Smaranda Diaconescu, et al.
Published: (2020-08-01)

Pancreatic Involvement in Pediatric Inflammatory Bowel Disease
by: Javier Martín-de-Carpi, et al.
Published: (2017-10-01)

Vaccination therapy for inflammatory bowel disease
by: Yafei Liu, et al.
Published: (2023-08-01)

Vaccination for Inflammatory Bowel Disease Patients
by: Evy Yunihastuti
Published: (2022-05-01)

The use of chromoendoscopy for surveillance of inflammatory bowel disease
by: Gary R. Lichtenstein, MD, et al.
Published: (2018-02-01)

Multiplexed suspension array immunoassays for detection of antibodies to pneumococcal polysaccharide and conjugate vaccines
by: Sherry A. Dunbar
Published: (2023-11-01)

Antibody enhanced HPLC for serotype-specific quantitation of polysaccharides in pneumococcal conjugate vaccine
by: James Z. Deng, et al.
Published: (2023-01-01)

Complementary Role of CD4+ T Cells in Response to Pneumococcal Polysaccharide Vaccines in Humans
by: Vibha Jha, et al.
Published: (2019-02-01)

Ineffectiveness for infants of immunization of mothers with pneumococcal capsular polysaccharide vaccine during pregnancy
by: Claudia R.C. Lopes, et al.